http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101288144-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 |
| filingDate | 2006-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2013-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101288144-B1 |
| titleOfInvention | Thienopyrimidine derivatives |
| abstract | The present invention is formula (I)n n n n n n n n In formula, R < 1> represents a hydrogen atom, an alkyl group, etc .;n n n R 2 represents a hydrogen atom, an alkyl group, an amino group or the like;n n n R 3 represents an alkyl group, an alkenyl group, an alkylthio group or the like or a group of YX-, orn n n R 2 and R 3 may be combined to form a tetramethylene group;n n n X represents a direct bond or a linking group such as CH 2 , CH (OH), S, O, NH, or the like;n n n Y represents a substituted or unsubstituted aromatic carbocyclic group, aromatic heterocyclic group, cycloalkyl group, saturated heterocyclic group and the like;n n n Z represents S or O;n n n n has a PDE9 inhibitory effect, indicated by indicating an integer of 0 or 1 to 4, urinary obstruction accompanying overactive bladder, urinary frequency, urinary incontinence, enlarged prostate, urolithiasis, Alzheimer's disease, chronic obstructive pulmonary disease, myocardial To provide a thienopyrimidine derivative or salt thereof useful in the prevention or treatment of infarction, thrombosis, diabetes and the like. |
| priorityDate | 2005-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 428.